Your browser is no longer supported. Please, upgrade your browser.
Settings
ESPR Esperion Therapeutics, Inc. daily Stock Chart
ESPR [NASD]
Esperion Therapeutics, Inc.
Index- P/E- EPS (ttm)-4.48 Insider Own31.62% Shs Outstand21.99M Perf Week-2.13%
Market Cap1.05B Forward P/E- EPS next Y-4.77 Insider Trans-10.74% Shs Float19.61M Perf Month16.31%
Income-100.90M PEG- EPS next Q-1.61 Inst Own97.10% Short Float31.86% Perf Quarter30.04%
Sales- P/S- EPS this Y-47.10% Inst Trans-0.61% Short Ratio9.14 Perf Half Y330.60%
Book/sh8.53 P/B5.59 EPS next Y28.70% ROA-40.30% Target Price52.00 Perf Year321.84%
Cash/sh8.27 P/C5.77 EPS next 5Y9.30% ROE-42.80% 52W Range9.40 - 50.52 Perf YTD281.07%
Dividend- P/FCF- EPS past 5Y38.00% ROI- 52W High-5.56% Beta2.72
Dividend %- Quick Ratio8.70 Sales past 5Y- Gross Margin- 52W Low407.55% ATR2.48
Employees44 Current Ratio8.70 Sales Q/Q- Oper. Margin- RSI (14)62.18 Volatility5.21% 5.61%
OptionableYes Debt/Eq0.01 EPS Q/Q-177.60% Profit Margin- Rel Volume0.54 Prev Close48.80
ShortableYes LT Debt/Eq0.00 EarningsAug 03 AMC Payout- Avg Volume683.46K Price47.71
Recom2.20 SMA202.76% SMA5020.86% SMA20087.60% Volume366,131 Change-2.23%
Jul-11-17Initiated Jefferies Hold
Jun-27-17Reiterated Stifel Buy $45 → $60
Jun-23-17Initiated Deutsche Bank Buy $48
Mar-30-17Upgrade UBS Neutral → Buy $23 → $52
Mar-20-17Upgrade Credit Suisse Underperform → Neutral
Feb-28-17Upgrade Citigroup Neutral → Buy
Feb-23-17Reiterated RBC Capital Mkts Sector Perform $20 → $30
Nov-14-16Downgrade Citigroup Buy → Neutral
Jul-05-16Downgrade WallachBeth Buy → Hold $35
Jun-30-16Reiterated Needham Buy $77 → $25
Jun-29-16Downgrade RBC Capital Mkts Outperform → Sector Perform $30 → $15
Jun-29-16Downgrade JP Morgan Overweight → Neutral
Jun-29-16Downgrade Credit Suisse Neutral → Underperform
Feb-26-16Reiterated Chardan Capital Markets Neutral $18 → $13
Feb-25-16Reiterated Stifel Buy $105 → $64
Dec-15-15Reiterated RBC Capital Mkts Outperform $65 → $40
Nov-06-15Reiterated RBC Capital Mkts Outperform $105 → $65
Oct-26-15Initiated WallachBeth Buy $34
Oct-26-15Initiated Lake Street Buy $94
Sep-30-15Upgrade Chardan Capital Markets Sell → Neutral $29 → $18
Jul-21-17 02:42PM  3 Been-There-Done-That Biotech CEOs Who Are Doing it Again Motley Fool
Jul-20-17 09:02PM  3 Hottest Biotech Stocks of 2017 -- Are They Still Buys Now? Motley Fool +5.63%
Jul-17-17 07:00AM  3 Small Biotech Stocks Being Run by Proven Winners Motley Fool
Jun-30-17 05:46PM  3 Stocks That Turned $7,000 Into As Much As $37,000 So Far in 2017 Motley Fool
Jun-29-17 08:20AM  Esperion Therapeutics (ESPR) Looks Good: Stock Gains 10.4% Zacks
08:00AM  Today's Research Reports on Stocks to Watch: Heat Biologics Inc. and Esperion Therapeutics Accesswire
Jun-28-17 06:14PM  Here's Why Shares of Esperion Therapeutics (ESPR) Popped Today Zacks +10.38%
04:17PM  Esperion Breaks Out On Cholesterol Tie-Up With Dow's Merck Investor's Business Daily
10:30AM  Esperion's Combo Cholesterol Candidate Enters Phase III Zacks
Jun-26-17 04:05PM  Esperion Announces FDA Confirmation of Regulatory Pathway to Approval for the Combination of Bempedoic Acid and Ezetimibe GlobeNewswire
Jun-23-17 09:54AM  Deutsche Bank's Take On Big Pharma: 3 Buys And A Hold Benzinga
Jun-22-17 03:42PM  If Esperion Wants to Market the Next Big Cholesterol Drug, It Will Take Strategy Motley Fool
12:19PM  3 Hot Plays in the Resurgent Biotech Sector Investopedia
Jun-21-17 04:33PM  Biotechs Surge As Generalists Return Amid Subsiding Trump Woes Investor's Business Daily +19.21%
Jun-14-17 04:30PM  Esperion to Present at the JMP Securities 2017 Life Sciences Conference GlobeNewswire
Jun-09-17 01:19PM  Apple Could Explode Higher to $200 a Share If This Chart Pattern Is Correct TheStreet.com
May-31-17 04:30PM  Esperion to Present at the Jefferies 2017 Global Healthcare Conference GlobeNewswire
May-22-17 08:05AM  Esperion Provides Update on Common Stock Trading Activity GlobeNewswire
May-19-17 04:30PM  Esperion to Participate in Fireside Chat at the UBS Global Healthcare Conference GlobeNewswire -8.14%
May-18-17 04:30PM  Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
May-12-17 04:30PM  Esperion to Participate in Fireside Chat at the Bank of America Merrill Lynch 2017 Healthcare Conference GlobeNewswire
May-08-17 08:00AM  Today's Research Report on Biotech Stocks to Watch: Immunomedics and Esperion Therapeutics Accesswire
May-06-17 08:01AM  Why Esperion Therapeutics Shares Were Flat In April Motley Fool
May-05-17 05:02AM  Esperion Therapeutics reports 1Q loss Associated Press -5.22%
May-04-17 04:05PM  Esperion Provides Bempedoic Acid Development Program Updates; Reports First Quarter 2017 Financial Results GlobeNewswire
May-01-17 02:32PM  3 Best Biotech Stocks During Trump's First 100 Days Motley Fool
Apr-28-17 09:21AM  Biotech And Pharma Industry And Stock News Investor's Business Daily
Apr-26-17 05:28PM  Amgen Trips Amid Rivals: Sales Miss By $100 Million, But Earnings Top Investor's Business Daily
Apr-11-17 07:02AM  3 Clinical-Stage Biotech Stocks That Could Be About to Strike It Rich Motley Fool
Apr-10-17 06:51PM  Cramer's lightning round: I may be alone on this, but this e-commerce play is going higher CNBC +7.57%
Apr-07-17 09:30AM  The Zacks Analyst Blog Highlights: Esperion Therapeutics, Vertex Pharmaceuticals, Nektar Therapeutics, Argos Therapeutics and Cidara Therapeutics Zacks
Apr-06-17 09:32AM  3 of the Best & Worst Performing Drug Stocks of Q1 Zacks
Mar-31-17 08:21AM  Could Pfizer Buy Esperion Therapeutics? Motley Fool
Mar-30-17 04:20PM  The 3 Best Cholesterol Drug Stocks to Buy in 2017 Motley Fool
04:08PM  Which Biotechs Are Buyable As Sector Recovers In 2017? Investor's Business Daily
10:33AM  5 Top Performing Stocks of the Best ETF of Q1 Zacks
09:03AM  Esperion Therapeutics upgraded by UBS
Mar-28-17 04:30PM  Esperion to Participate in Fireside Chat at the 16th Annual Needham Healthcare Conference GlobeNewswire -6.82%
Mar-24-17 12:00PM  3 Hot Biotech Stocks Now Motley Fool
Mar-21-17 10:10AM  Company News for March 21, 2017 Zacks -5.26%
09:32AM  Biotech Premarket Movers: Esperion, Minerva and BioCryst
09:30AM  The Difference Between Spectacular News and No News Accesswire
Mar-20-17 08:08PM  Esperion Therapeutics Inc (ESPR): Get It While Its Cheap Insider Monkey +74.14%
06:21PM  After-hours buzz: ESPR, NKTR, MMSI & more at CNBC
05:02PM  Here's What Pushed Esperion Therapeutics Inc Stock Higher Today at Motley Fool
04:09PM  Esperion And Medicines Co. Recover From Amgen-Induced Pitfall
02:03PM  How to Trade Monday's Most Active Stocks - AMD, Esperion Therapeutics, Nokia and More
12:42PM  Nektar, AMD, Esperion, and More: Heres Why These Five Stocks Are Surging at Insider Monkey
12:05PM  Esperion Gets FDA Nod for Cholesterol Drug Program at Investopedia
11:01AM  Esperion Therapeutics stock surges 52% after it says the FDA gave its drug program positive feedback at MarketWatch
10:55AM  Mondays Top Biopharma Movers
09:35AM  Biotech Premarket Movers: CytomX, Aevi, Esperion
07:46AM  ESPERION THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:32AM  Esperion Therapeutics Sees Clear FDA Path For Its Heart Drug at Forbes
07:30AM  Esperion Announces FDA Confirmation Regarding Regulatory Pathway to Approval for an LDL-C Lowering Indication for Bempedoic Acid GlobeNewswire
Mar-17-17 04:50PM  Esperion's Dive On Amgen Heart Study 'Counterintuitive' On Pricing -20.17%
04:28PM  Amgen Tanks On Heart Study; Shares Of Other Drugmakers Tumble
02:56PM  Amgen, Esperion, AmTrust Financial and More: What is Going On With These Falling Stocks? at Insider Monkey
01:18PM  Here's Why Amgen, The Medicines Company, and Esperion Therapeutics Are All Tanking Today at Motley Fool
11:03AM  [video]AveXis, Esperion and Amgen Among Biotech Movers
Mar-14-17 04:06PM  Amgen Could Boost Rivals On Positive Heart-Disease Study: Analyst
Mar-09-17 08:15AM  Esperion Therapeutics (ESPR) Jumps: Stock Moves Up 8.6%
Mar-08-17 04:26PM  Puma Leads Massive Biotech Surge As Esperion Hits 15-Month High +8.59%
Mar-07-17 08:47AM  ESPERION THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:30AM  Esperion Announces Initiation of Phase 2 Triplet Oral Therapy Study of Bempedoic Acid/Ezetimibe/Atorvastatin GlobeNewswire
Mar-06-17 08:30AM  Esperion Announces Oral Presentation on Genetic Validation of ATP Citrate Lyase Inhibition at the American College of Cardiology 66th Annual Scientific Session GlobeNewswire
Mar-02-17 03:34PM  Biotechs Breaking Out On Drug Development News at Forbes
Mar-01-17 04:21PM  Here's Why Esperion Therapeutics Inc Stock Popped Today at Motley Fool +16.32%
Feb-28-17 01:04PM  ESPERION THERAPEUTICS, INC. Financials
Feb-27-17 07:39PM  Cramer's lightning round: The only Chinese stock I will recommend at CNBC +6.50%
Feb-24-17 05:42PM  3 Biotech Long Shots: Boom Or Bust? at Motley Fool
Feb-22-17 08:04AM  Esperion Therapeutics reports 4Q loss -7.74%
07:47AM  ESPERION THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
07:30AM  Esperion Provides Bempedoic Acid Development Program Update; Reports Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
Feb-15-17 04:30PM  Esperion to Participate in Fireside Chat at RBC Capital Markets Global Healthcare Conference GlobeNewswire
Feb-13-17 04:07PM  Esperion Positioned to Capitalize on Phase III Trials
Feb-09-17 12:37PM  Harry Boxers stocks to watch: biotechnology and technology at MarketWatch
Feb-08-17 01:49PM  Four Biotech Stocks Breaking Out at Forbes
Feb-07-17 12:50PM  Whats Next For Esperion Therapeutics Inc (ESPR)? at Insider Monkey +14.04%
Feb-06-17 09:30AM  Mergers & Acquisitions Could be a Key Catalyst Sending These Biotech Stocks to New Highs in 2017 Accesswire +7.42%
Feb-03-17 03:38PM  Why Esperion Therapeutics, Inc. Is Soaring Today at Motley Fool +29.25%
Jan-25-17 08:05AM  Esperion Completes Enrollment of Pivotal Phase 3 Long-Term Safety and Tolerability Study of Bempedoic Acid in Patients with Hypercholesterolemia GlobeNewswire +5.89%
Jan-09-17 04:07PM  ESPERION THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:05AM  Esperion Announces Initiation of Global Cardiovascular Outcomes Trial for Bempedoic Acid GlobeNewswire
Jan-08-17 04:00PM  Esperion Announces Initiation of Three Pivotal Phase 3 Studies for Bempedoic Acid GlobeNewswire
Jan-04-17 05:00PM  Esperion to Present at the 35th Annual J.P. Morgan Healthcare Conference GlobeNewswire +7.84%
Dec-09-16 05:26PM  Esperion Therapeutics Inc (ESPR): Smart Money Doubles Down at Insider Monkey
04:31PM  ESPERION THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and E
Dec-02-16 04:05PM  Amgen, Regeneron 2017 LDL-Busters Could Boost This Small-Cap Biotech
Nov-29-16 11:59AM  Esperion Therapeutics, Inc. :ESPR-US: Earnings Analysis: Q3, 2016 By the Numbers : November 29, 2016
Nov-28-16 04:30PM  Esperion Therapeutics Announces Publication of Definitive Paper on Bempedoic Acid Mechanism of Action in Nature Communications GlobeNewswire -6.46%
Nov-09-16 04:30PM  Esperion Therapeutics to Present at the Stifel 2016 Healthcare Conference GlobeNewswire +9.52%
Nov-03-16 07:11PM  Esperion Therapeutics reports 3Q loss -7.57%
04:39PM  ESPERION THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
04:37PM  ESPERION THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
04:05PM  Esperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Third Quarter 2016 Financial Results GlobeNewswire
Nov-01-16 04:30PM  Esperion Therapeutics to Present at the Credit Suisse 25th Annual Healthcare Conference GlobeNewswire
12:39PM  Pfizer's Surprising News Upends the Market for Next-Gen Cholesterol Busters at Motley Fool
Oct-14-16 09:22AM  Credit Suisse Changes Its View On Esperion Therapeutics, Raises Price Target -7.38%
Oct-13-16 07:46AM  ESPERION THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits +5.60%
Esperion Therapeutics, Inc., a lipid management company, focuses on developing and commercializing oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol (LDL-C). Its lead product candidate is Bempedoic acid, an inhibitor of ATP-citrate lyase that reduces cholesterol biosynthesis that is in Phase III long-term safety and tolerability study. Esperion Therapeutics, Inc. was founded in 2008 and is headquartered in Ann Arbor, Michigan.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OMENN GILBERT SDirectorMar 21Buy42.261,00042,2601,000Mar 22 08:02 AM
JANNEY DANIELDirectorMar 21Sale45.80350,00016,029,2631,359,967Mar 23 04:45 PM
GOLDSTEIN DOV A MDDirectorMar 21Sale43.48487,35821,190,3261,149,767Mar 23 04:37 PM
Lalwani Narendra D.Chief Operating OfficerNov 01Buy9.935,00049,6505,000Nov 03 05:58 PM